-
1
-
-
33745930814
-
Complement and demyelinating disease: no MAC needed?
-
Barnum S.R., and Szalai A.J. Complement and demyelinating disease: no MAC needed?. Brain Res. Rev. 52 (2006) 58-68
-
(2006)
Brain Res. Rev.
, vol.52
, pp. 58-68
-
-
Barnum, S.R.1
Szalai, A.J.2
-
2
-
-
4644328027
-
Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis
-
Boos L., Campbell I.L., Ames R., Wetsel R.A., and Barnum S.R. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 4708-4714
-
(2004)
J. Immunol.
, vol.173
, pp. 4708-4714
-
-
Boos, L.1
Campbell, I.L.2
Ames, R.3
Wetsel, R.A.4
Barnum, S.R.5
-
3
-
-
33947110020
-
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
-
Chen N.J., Mirtsos C., Suh D., Lu Y.C., Lin W.J., McKerlie C., Lee T., Baribault H., Tian H., and Yeh W.C. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446 (2007) 203-207
-
(2007)
Nature
, vol.446
, pp. 203-207
-
-
Chen, N.J.1
Mirtsos, C.2
Suh, D.3
Lu, Y.C.4
Lin, W.J.5
McKerlie, C.6
Lee, T.7
Baribault, H.8
Tian, H.9
Yeh, W.C.10
-
4
-
-
0001754187
-
Characterization of complement anaphylatoxina and their biological responses
-
Volanakis J.E., and Frank M.M. (Eds), Marcel Dekker, Inc., New York
-
Ember J.A., Jagels M.A., and Hugli T.E. Characterization of complement anaphylatoxina and their biological responses. In: Volanakis J.E., and Frank M.M. (Eds). The Human Complement System in Health and Disease (1998), Marcel Dekker, Inc., New York 241-284
-
(1998)
The Human Complement System in Health and Disease
, pp. 241-284
-
-
Ember, J.A.1
Jagels, M.A.2
Hugli, T.E.3
-
5
-
-
0029795542
-
The C5a chemoattractant receptor mediates mucosal defence to infection
-
Hopken U.E., Lu B., Gerard N.P., and Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383 (1996) 86-89
-
(1996)
Nature
, vol.383
, pp. 86-89
-
-
Hopken, U.E.1
Lu, B.2
Gerard, N.P.3
Gerard, C.4
-
6
-
-
0034670027
-
Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock
-
Kildsgaard J., Hollmann T.J., Matthews K.W., Bian K., Murad F., and Wetsel R.A. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol. 165 (2000) 5406-5409
-
(2000)
J. Immunol.
, vol.165
, pp. 5406-5409
-
-
Kildsgaard, J.1
Hollmann, T.J.2
Matthews, K.W.3
Bian, K.4
Murad, F.5
Wetsel, R.A.6
-
7
-
-
68049129555
-
The role of the anaphylatoxins in health and disease
-
Klos A., Tenner A.J., Johswich K.O., Ager R.R., Reis E.S., and Kohl J. The role of the anaphylatoxins in health and disease. Mol. Immunol. (2009)
-
(2009)
Mol. Immunol.
-
-
Klos, A.1
Tenner, A.J.2
Johswich, K.O.3
Ager, R.R.4
Reis, E.S.5
Kohl, J.6
-
8
-
-
9644302961
-
Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats
-
Morgan B.P., Griffiths M., Khanom H., Taylor S.M., and Neal J.W. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin. Exp. Immunol. 138 (2004) 430-438
-
(2004)
Clin. Exp. Immunol.
, vol.138
, pp. 430-438
-
-
Morgan, B.P.1
Griffiths, M.2
Khanom, H.3
Taylor, S.M.4
Neal, J.W.5
-
9
-
-
0036232710
-
Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis
-
Reiman R., Gerard C., Campbell I.L., and Barnum S.R. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Eur. J. Immunol. 32 (2002) 1157-1163
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 1157-1163
-
-
Reiman, R.1
Gerard, C.2
Campbell, I.L.3
Barnum, S.R.4
-
10
-
-
26944477028
-
Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis
-
Reiman R., Torres A.C., Martin B.K., Ting J.P., Campbell I.L., and Barnum S.R. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis. Neurosci. Lett. (2005)
-
(2005)
Neurosci. Lett.
-
-
Reiman, R.1
Torres, A.C.2
Martin, B.K.3
Ting, J.P.4
Campbell, I.L.5
Barnum, S.R.6
-
11
-
-
38149111863
-
Differential expression of b2-integrins and cytokine production between gd and ab T cells in experimental autoimmune encephalomyelitis
-
Smith S.S., and Barnum S.R. Differential expression of b2-integrins and cytokine production between gd and ab T cells in experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 83 (2008) 71-79
-
(2008)
J. Leukoc. Biol.
, vol.83
, pp. 71-79
-
-
Smith, S.S.1
Barnum, S.R.2
-
12
-
-
48149091591
-
Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice
-
Smith S.S., Ludwig M., Wohler J.E., Bullard D.C., Szalai A.J., and Barnum S.R. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice. Neurosci. Lett. 442 (2008) 158-160
-
(2008)
Neurosci. Lett.
, vol.442
, pp. 158-160
-
-
Smith, S.S.1
Ludwig, M.2
Wohler, J.E.3
Bullard, D.C.4
Szalai, A.J.5
Barnum, S.R.6
|